The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Trump Administration Seeks Emergency Order to Resume White House Ballroom Construction
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
U.S. Markets Post Strong Weekly Gains Despite Middle East Tensions and Rising Energy Prices
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Oil Prices Rebound as Hormuz Disruptions and Middle East Tensions Rattle Markets
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
DOJ Backs Jeanine Pirro-Led Investigation Into Federal Reserve Chair Jerome Powell
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 



